“In 2015, the British Medical Journal published a meta-analysis looking at randomised controlled trials (RCTs) that were available to US and UK regulatory committees that adopted low-fat dietary guidelines in the 1970s and 1980s to supposedly reduce coronary heart disease (CHD). The authors of the study state that to date, no analysis of the evidence base for recommending a low-fat diet to reduce heart disease has ever been studied. So the authors conducted a systematic review and meta-analysis of the RCTs that were published prior to 1983, which examined the relationship between dietary fat, serum cholesterol and the development of coronary heart disease. After analyzing multiple studies that included 2467 males, the authors found "no differences in all-cause mortality and non-significant differences in CHD mortality, resulting from the dietary interventions." They therefore concluded that: "Dietary recommendations were introduced for 220 million US and 56 million UK citizens by 1983, in the absence of supporting evidence from RCTs." How many lives have been ruined by the low-fat theory of heart disease?
The cholesterol-lowering statin drug empire continues to crumble. On February 15, 2015, the Sunday Express in the UK published a headline story stating that Oxford professor Dr. Rory Collins, whose research had been used to support putting millions of patients on statin drugs, was reassessing the data behind those studies for possible drug side effects. According to the Express: "Although the original research looked at the effect of statins on the heart and considered cancer risks it did not examine other side effects." This announcement by Dr. Collins is stunning, to say the least, and points to a massive cover-up and scandal related to statin drugs.
Here is a fact that has been known for quite a long time, but is still news to many people: People with higher cholesterol levels live longer than people with lower cholesterol levels. The reason why this fact is not well-known to the general public is because it would put a huge dent into a $100 BILLION drug market for statin drugs. With approximately one out of every 4 Americans over the age of 50 currently prescribed a statin drug, a drug with very serious side effects, this is certainly one issue you should investigate yourself.
Today’s senior care provider will need to spend time researching the dangers of pharmaceutical drugs and the benefits of natural products outside of the medical system, because no one else is looking out for the interests of the elderly. Read more:
A study published in 2014 in the international journal Drug Safety found a positive association between regular statin drug use and Bell's palsy, a neurologic disorder. This study confirms what Dr. Stephanie Seneff published back in 2009, showing how statin drugs used to lower cholesterol could be a main cause of Alzheimer's and other neurological diseases in old age.
In a new Reuters’ story, Jessica Dye reports that U.S. women who say Lipitor gave them type-2 diabetes shot up from 56 to almost 1,000 court lawsuits in less than 5 months. The number of cases could ultimately reach 10,000 or more.
Regeneron Pharmaceuticals Inc. and Sanofi SA are spending $67.5 million to purchase a voucher that will allow them to get the FDA to fast-track approval of a new class of cholesterol drugs, in hopes of beating a competitor to market.
Top Irish surgeon warns statins raise chances of cancer and Parkinson's in otherwise healthy people. Sherif Sultan, of University College Hospital in Galway, warned that statin use can increase the risk of diabetes, cataracts and male impotence.
The $100 billion dollar cholesterol-lowering statin drug industry is under attack, as thousands of Americans are filing lawsuits against the manufacturers cholesterol-lowering drugs such as Lipitor.
Millions of people over the age of 50 risk harming their health if they follow new NHS guidance telling them to take statins, leading doctors have warned the Health Secretary.